These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Correlation of initial thiothixene serum levels and clinical response. Comparison of fluorometric, gas chromatographic, and RBC assays. Yesavage JA; Holman CA; Cohn R; Lombrozo L Arch Gen Psychiatry; 1983 Mar; 40(3):301-4. PubMed ID: 6830409 [TBL] [Abstract][Full Text] [Related]
6. Penfluridol and thiothixene. Dosage, plasma levels and changes in psychopathology. Jacobsson L; von Knorring L; Mattsson B; Mjörndal T; Oreland L; Perris C; Rapp W; Edenius B; Kettner B; Magnusson KE; Villemoes P Int Pharmacopsychiatry; 1976; 11(4):206-14. PubMed ID: 795779 [TBL] [Abstract][Full Text] [Related]
7. Tardive dyskinesia and steady-state serum levels of thiothixene. Yesavage JA; Tanke ED; Sheikh JI Arch Gen Psychiatry; 1987 Oct; 44(10):913-5. PubMed ID: 2889439 [TBL] [Abstract][Full Text] [Related]
8. Inpatient violence and the schizophrenic patient: an inverse correlation between danger-related events and neuroleptic levels. Yesavage JA Biol Psychiatry; 1982 Nov; 17(11):1331-7. PubMed ID: 7150681 [TBL] [Abstract][Full Text] [Related]
9. Neuroleptic serum levels measured by radioreceptor assay and clinical response in schizophrenic patients. Tune LE; Creese I; DePaulo JR; Slavney PR; Snyder SH J Nerv Ment Dis; 1981 Jan; 169(1):60-3. PubMed ID: 6108981 [TBL] [Abstract][Full Text] [Related]
11. Total and free plasma neuroleptic levels in schizophrenic patients. Tang SW; Glaister J; Davidson L; Toth R; Jeffries JJ; Seeman P Psychiatry Res; 1984 Dec; 13(4):285-93. PubMed ID: 6596586 [TBL] [Abstract][Full Text] [Related]
12. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia. Knight RG; Harrison A N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155 [TBL] [Abstract][Full Text] [Related]
13. Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents. Realmuto GM; Erickson WD; Yellin AM; Hopwood JH; Greenberg LM Am J Psychiatry; 1984 Mar; 141(3):440-2. PubMed ID: 6367494 [TBL] [Abstract][Full Text] [Related]
15. A double-blind comparison of melperone and thiothixene in psychotic women using a new rating scale, the CPRS. Bjerkenstedt L; Härnryd C; Grimm V; Gullberg B; Sedvall G Arch Psychiatr Nervenkr (1970); 1978 Dec; 226(3):157-72. PubMed ID: 32861 [TBL] [Abstract][Full Text] [Related]
16. Haloperidol and thiothixene in the long-term treatment of chronic schizophrenic outpatients in an urban community: social and vocational adjustment. Engelhardt DM; Rudorfer L; Rosen B J Clin Psychiatry; 1978 Dec; 39(12):834-40. PubMed ID: 721787 [TBL] [Abstract][Full Text] [Related]
17. Once versus thrice daily thiothixene in the treatment of schizophrenic in-patients. Lee JH; Branchey M; Haher EJ; Varga E; Simpson GM Br J Psychiatry; 1974 Jul; 125(0):73-8. PubMed ID: 4604854 [No Abstract] [Full Text] [Related]
18. Plasma concentrations of thiothixene and clinical response in treatment-resistant schizophrenics. Hollister LE; Lombrozo L; Huang CC Int Clin Psychopharmacol; 1987 Jan; 2(1):77-82. PubMed ID: 3312399 [TBL] [Abstract][Full Text] [Related]
19. Serum neuroleptic concentrations and clinical response: a radioreceptor assay investigation of acutely psychotic patients. Kucharski LT; Alexander P; Tune L; Coyle J Psychopharmacology (Berl); 1984; 82(3):194-8. PubMed ID: 6144127 [TBL] [Abstract][Full Text] [Related]
20. Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study. Sarai K; Okada M Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):38-46. PubMed ID: 2883680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]